ALZCHEM GROUP AG |
Market Closed -
Other stock markets
|
Pre-market 02:40:30 am | |||
| 45.8 EUR | +2.00% |
|
46.4 | +1.31% |
| Mar. 15 | German arms industry receives EU millions for projects | DP |
| Mar. 01 | Transcript : AlzChem Group AG, 2023 Earnings Call, Mar 01, 2024 |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 217.8 | 217.8 | 237.8 | 171.3 | 263.5 | 466.1 | - | - |
| Enterprise Value (EV) 1 | 271.4 | 269.7 | 277.6 | 256 | 309.1 | 502.6 | 498.9 | 475.4 |
| P/E ratio | 12.1 x | 11 x | 8.6 x | 5.71 x | 7.65 x | 11.4 x | 10.3 x | 9.12 x |
| Yield | 3.5% | 3.6% | 4.27% | 6.21% | 4.62% | 2.89% | 3.21% | 3.7% |
| Capitalization / Revenue | 0.58 x | 0.57 x | 0.56 x | 0.32 x | 0.49 x | 0.83 x | 0.79 x | 0.75 x |
| EV / Revenue | 0.72 x | 0.71 x | 0.66 x | 0.47 x | 0.57 x | 0.89 x | 0.85 x | 0.77 x |
| EV / EBITDA | 5.42 x | 5.01 x | 4.48 x | 4.17 x | 3.8 x | 5.71 x | 5.27 x | 4.57 x |
| EV / FCF | 121 x | 13.6 x | 19.2 x | 7.82 x | 5.93 x | 18.2 x | 16.5 x | 12.3 x |
| FCF Yield | 0.83% | 7.37% | 5.22% | 12.8% | 16.9% | 5.48% | 6.05% | 8.14% |
| Price to Book | 3.64 x | 3.26 x | 2.71 x | 1.19 x | 1.64 x | 2.41 x | 2.07 x | 1.79 x |
| Nbr of stocks (in thousands) | 10,176 | 10,176 | 10,163 | 10,136 | 10,136 | 10,176 | - | - |
| Reference price 2 | 21.40 | 21.40 | 23.40 | 16.90 | 26.00 | 45.80 | 45.80 | 45.80 |
| Announcement Date | 3/24/20 | 3/19/21 | 2/24/22 | 2/28/23 | 3/1/24 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 376.1 | 379.3 | 422.3 | 542.2 | 540.6 | 564.3 | 589 | 617.8 |
| EBITDA 1 | 50.08 | 53.8 | 62 | 61.44 | 81.37 | 88.02 | 94.7 | 104.1 |
| EBIT 1 | 30.59 | 30.71 | 37.57 | 35.9 | 55.47 | 61.02 | 66.88 | 71.98 |
| Operating Margin | 8.13% | 8.1% | 8.9% | 6.62% | 10.26% | 10.81% | 11.35% | 11.65% |
| Earnings before Tax (EBT) 1 | 25.49 | 27.2 | 36.51 | 41.28 | 48.19 | 57.18 | 63.45 | 71.53 |
| Net income 1 | 17.98 | 19.69 | 27.59 | 30.05 | 34.62 | 40.88 | 45.38 | 51.17 |
| Net margin | 4.78% | 5.19% | 6.53% | 5.54% | 6.4% | 7.24% | 7.7% | 8.28% |
| EPS 2 | 1.770 | 1.940 | 2.720 | 2.960 | 3.400 | 4.011 | 4.458 | 5.023 |
| Free Cash Flow 1 | 2.249 | 19.88 | 14.48 | 32.75 | 52.12 | 27.55 | 30.17 | 38.7 |
| FCF margin | 0.6% | 5.24% | 3.43% | 6.04% | 9.64% | 4.88% | 5.12% | 6.26% |
| FCF Conversion (EBITDA) | 4.49% | 36.94% | 23.36% | 53.3% | 64.05% | 31.3% | 31.85% | 37.19% |
| FCF Conversion (Net income) | 12.51% | 100.93% | 52.48% | 108.98% | 150.55% | 67.4% | 66.48% | 75.64% |
| Dividend per Share 2 | 0.7500 | 0.7700 | 1.000 | 1.050 | 1.200 | 1.325 | 1.470 | 1.697 |
| Announcement Date | 3/24/20 | 3/19/21 | 2/24/22 | 2/28/23 | 3/1/24 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 95.92 | 129.4 | 140.4 | 139.2 | 133.2 | 150.4 | 126.6 | - | 142.8 | 146 | 132 | 279 |
| EBITDA 1 | 13.84 | 17.07 | 17.81 | 12.15 | 14.42 | 18.92 | 17.87 | 19.53 | 25.05 | 25.5 | 20.4 | 45.9 |
| EBIT | 7.632 | - | - | 5.823 | - | 12.6 | 11.54 | - | 18.38 | - | - | - |
| Operating Margin | 7.96% | - | - | 4.18% | - | 8.37% | 9.11% | - | 12.87% | - | - | - |
| Earnings before Tax (EBT) | - | - | - | - | - | - | - | - | 15.41 | - | - | - |
| Net income | 4.69 | 7.698 | - | 5.934 | - | 7.667 | - | - | 11.14 | - | - | - |
| Net margin | 4.89% | 5.95% | - | 4.26% | - | 5.1% | - | - | 7.8% | - | - | - |
| EPS | 0.4600 | 0.7600 | - | 0.5900 | - | 0.7600 | - | - | 1.090 | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/11/21 | 4/28/22 | 7/26/22 | 10/26/22 | 2/28/23 | 5/4/23 | 8/3/23 | 12/1/23 | 3/1/24 | - | - | - |
1EUR in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 53.6 | 51.9 | 39.8 | 84.7 | 45.6 | 36.6 | 32.8 | 9.33 |
| Net Cash position 1 | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 1.071 x | 0.9654 x | 0.6413 x | 1.378 x | 0.5606 x | 0.4152 x | 0.3464 x | 0.0897 x |
| Free Cash Flow 1 | 2.25 | 19.9 | 14.5 | 32.8 | 52.1 | 27.6 | 30.2 | 38.7 |
| ROE (net income / shareholders' equity) | 28.4% | 31.1% | 35.7% | 25.9% | 22.7% | 21.4% | 20.6% | 20.3% |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share 2 | 5.870 | 6.570 | 8.650 | 14.20 | 15.90 | 19.00 | 22.10 | 25.60 |
| Cash Flow per Share 2 | 0.2200 | 4.790 | 4.240 | 0.4200 | 7.150 | 6.350 | 6.800 | 7.360 |
| Capex 1 | 41.4 | 28.8 | 28.5 | 29.1 | 20.6 | 37.7 | 41 | 41.5 |
| Capex / Sales | 11% | 7.6% | 6.76% | 5.36% | 3.8% | 6.67% | 6.95% | 6.72% |
| Announcement Date | 3/24/20 | 3/19/21 | 2/24/22 | 2/28/23 | 3/1/24 | - | - | - |
1EUR in Million2EUR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
45.8
EUR
Average target price
43.1
EUR
Spread / Average Target
-5.90%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +76.15% | 498M | |
| -0.19% | 74.89B | |
| +0.09% | 46.52B | |
| -4.19% | 30.82B | |
| +10.24% | 18.19B | |
| -10.05% | 11.54B | |
| +6.39% | 11.24B | |
| -8.09% | 9.73B | |
| +2.79% | 9.4B | |
| +5.73% | 9.37B |
- Stock Market
- Equities
- ACT Stock
- Financials AlzChem Group AG
